Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trypanosomal DNA consists of both nuclear and mitochondrial DNA, with the latter forming a complex catenated structure known as the kinetoplast. Kinetoplast DNA (kDNA) is essential for parasite survival, cell cycle progression, and infection. Replication and repair of this DNA require specialized enzymes, including unique DNA polymerases (such as POLIB, POLIC, and POLID in *T. brucei*)—each with specialized functions for mitochondrial DNA maintenance and repair. The nuclear DNA encodes the parasite’s major genes, while the mitochondrial kDNA supports essential oxidative phosphorylation processes. Trypanosomal DNA is targeted by drugs that induce DNA damage, inhibit replication, or disrupt essential repair processes, making it central to therapeutic intervention and diagnosis in trypanosomiasis. Overall, the term "Trypanosomal DNA" is broad and does not refer to a unique molecular target (receptor, enzyme, etc.), but it is often used as an umbrella descriptor for genetic or drug studies; greater specificity is typically necessary for scientific and therapeutic utility.
DNA damage induction (e.g., nitrofuran drugs produce reactive species that damage kDNA and nuclear DNA); Inhibition of DNA replication (targeting DNA polymerases or replication factors); Binding to the DNA minor groove or other DNA structures to interfere with function; Inhibition of repair enzymes (e.g., PARP inhibitors that affect DNA repair).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trypanosoma DNA.